|
||

* Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California 94305-5332; and The spindle assembly checkpoint prevents
cells whose spindles are defective or chromosomes are
misaligned from initiating anaphase and leaving mitosis. Studies of Xenopus egg extracts have implicated the
Erk2 mitogen-activated protein kinase (MAP kinase)
in this checkpoint. Other studies have suggested that MAP kinases might be important for normal mitotic
progression. Here we have investigated whether MAP
kinase function is required for mitotic progression or
the spindle assembly checkpoint in vivo in Xenopus
tadpole cells (XTC). We determined that Erk1 and/or Erk2 are present in the mitotic spindle during
prometaphase and metaphase, consistent with the idea
that MAP kinase might regulate or monitor the status
of the spindle. Next, we microinjected purified recombinant XCL100, a Xenopus MAP kinase phosphatase,
into XTC cells in various stages of mitosis to interfere
with MAP kinase activation. We found that mitotic
progression was unaffected by the phosphatase. However, XCL100 rendered the cells unable to remain arrested in mitosis after treatment with nocodazole. Cells injected with phosphatase at prometaphase or
metaphase exited mitosis in the presence of nocodazole
Preuss
Laboratory Molecular Neuro-oncology, Brain Tumor Research Center, University of California at San Francisco, San Francisco,
California 94143-0520
the chromosomes decondensed and the nuclear
envelope re-formed
whereas cells injected with buffer
or a catalytically inactive XCL100 mutant protein remained arrested in mitosis. Coinjection of constitutively active MAP kinase kinase-1, which opposes
XCL100's effects on MAP kinase, antagonized the effects of XCL100. Since the only known targets of MAP
kinase kinase-1 are Erk1 and Erk2, these findings argue that MAP kinase function is required for the spindle assembly checkpoint in XTC cells.
This article has been cited by other articles:
|
|